Response to: 'Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations' by Orsolini
et al
Ann Rheum Dis
.
2020 Nov;79(11):e151.
doi: 10.1136/annrheumdis-2019-215944.
Epub 2019 Jul 30.
Authors
Antonis Fanouriakis
1
,
George Bertsias
2
3
,
Dimitrios T Boumpas
4
5
Affiliations
1
Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece afanour@med.uoa.gr.
2
Department of Rheumatology, University Hospital of Heraklion, Heraklion, Greece.
3
Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Crete, Greece.
4
Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.
5
Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
PMID:
31362992
DOI:
10.1136/annrheumdis-2019-215944
No abstract available
Keywords:
disease activity; systemic lupus erythematosus; treatment.
Publication types
Comment
MeSH terms
Bone Density*
Bone and Bones
Comorbidity
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / epidemiology